Last data update: Oct 27, 2021 . (Total: 27269 Documents since 2020)
Records 1-4 (of 4 Records)
|Query Trace: BRCA1[original query]>>BRCA1[Gene]|
| Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.
Benusiglio Patrick R, et al. European journal of medical genetics 2020 11 0. 104098
| Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
Barata Pedro, et al. Journal for immunotherapy of cancer 2020 0 0. (2)
| Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019.
Vetter Monica Hagan, et al. American journal of obstetrics and gynecology 2020 5 0.
| BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic.
Minucci Angelo, et al. Molecular biology reports 2020 5 0.
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.